CRYSTAL KASPER: Open Payments
NPI 1093109886 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,927 in 41 payments from 12 companies in 2025. Trend: 2023 $1,648 · 2024 $2,095 · 2025 $1,927
Food & beverage: $1,927
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $410 |
| ABBVIE INC. | 10 | $394 |
| Abbott Laboratories | 3 | $353 |
| Dexcom, Inc. | 4 | $288 |
| Novo Nordisk Inc | 5 | $202 |
| Exact Sciences Corporation | 3 | $81 |
| Lilly USA, LLC | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 1 | $51 |
| Amgen Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $23 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, BREZTRI, Wegovy, AIRSUPRA, Dexcom G6 Transmitter, DEXCOM G7 GSS (161), FREESTYLE LIBRE 2.
Industry payments across FL — which companies pay providers there.
